Clinical Trials Sponsored by PCD Foundation

Total 16841 results

PKD Foundation

Recruiting

ADPKD Patient Registry (ADPKD)

Polycystic Kidney Diseases

United States
Emory University
PKD Foundation

Completed

ADPKD Cohort Study

Autosomal Dominant Polycystic Kidney Disease

United States
Columbia University
International OCD Foundation

Recruiting

Neural Correlates of Compulsivity

Obsessive-Compulsive Disorder

United States
University of Florida
International OCD Foundation

Recruiting

Paired tVNS With ERP in OCD

OCD

United States
University of Colorado, Denver
PKD Foundation

Completed

Time Restricted Feeding in Autosomal Dominant Polycystic Kidney Disease

Polycystic Kidney, Autosomal Dominant

United States
The Camelot Foundation
GM Harrington, PhD

Completed

Cardiovascular Outcomes Of Diet Counseling

Coronary Artery Disease | Obesity

United States
Massachusetts General Hospital
Foundation for OCD Research

Recruiting

Transcranial Direct Current Stimulation Potentiation of Fear Extinction in OCD

Obsessive-Compulsive Disorder

United States
Stanford University
Cornell University; Foundation for OCD Research

Recruiting

Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD

Obsessive-Compulsive Disorder

United States
Jesper Frank Christensen, PhD
Lundbeck Foundation; Region Capital Denmark; Beckett Foundation

Active, not recruiting

PREoperativ Study of Exercise Training (PRESET-RCT)

GastroEsophageal Cancer

Denmark
Paul Yates, MD, PhD
MEDARVA Foundation

Completed

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA) (TOGA)

Geographic Atrophy

United States
CHEOL WHAN LEE, MD, PhD.

Terminated

Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina

Coronary Artery Diseases

Korea, Republic of
CHEOL WHAN LEE, MD, PhD.
CardioVascular Research Foundation, Korea

Completed

Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)

Coronary Artery Disease

Korea, Republic of
Elizabeth F Sutton, PhD
Donaghue Medical Research Foundation

Not yet recruiting

Testing the Effectiveness of the Her Health Program to Add Healthcare Value in the Fourth Trimester (Her Health)

Pregnancy Related | Postpartum

United States
University of Bern
University of Southampton; Selbsthilfegruppe Kartagener Syndrom und Primäre... and other collaborators

Recruiting

COVID-19 in People With Primary Ciliary Dyskinesia

Primary Ciliary Dyskinesia

Switzerland
Michael A. Gelfand, MD, PhD
Epilepsy Foundation

Completed

Novel Helmet Design in Patients With Seizures

Generalized Tonic Clonic Seizure | Drug Resistant Epilepsy | Drop Seizures | Complex Partial Seizure | Fall Due to Seizure

United States
Finn, Olivera, PhD
Breast Cancer Research Foundation; A Glimmer of Hope Foundation

Recruiting

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

Ductal Carcinoma in Situ

United States
DR. DIANE CHISESI NFS. MD. PHD.
IRB

Not yet recruiting

Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor (NASBP-B-09)

Chronic Pain | Metastatic Breast Cancer | Tumor | Muscle Neoplasms

United States
Kristi G. Bache, PhD
Oslo University Hospital

Completed

The Norwegian Acute Stroke Prehospital Project (NASPP)

Traumatic Brain Injury | Acute Stroke

Norway
Marta Peciña, MD PhD
Brain & Behavior Research Foundation

Completed

Study of Naltrexone-Induced Blockade of Antidepressant Effects (SONRISA2)

Depression | Major Depressive Disorder

United States
Majanka H. Heijenbrok-Kal, PhD
Netherlands Brain Foundation

Not yet recruiting

ABI-aftercare in Motion: Multidisciplinary Aftercare in the Home Environment in Patients With Acquired Brain Injury (ABI-motion)

Acquired Brain Injury
Pfizer
PPD

Recruiting

A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

Atopic Dermatitis

United States
GlaxoSmithKline
PPD

Active, not recruiting

Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level (MATINEE)

Pulmonary Disease, Chronic Obstructive

United States, Australia, Argentina, Canada, France, Germany, Japan, Poland, Spain, Hungary, Belgium, Netherlands, Israel, Mexico, Austria, Korea, Republic of, China, Greece, Denmark, India, Sweden, Taiwan, United Kingdom, Italy, Brazil, New... and more
Mendus
PPD

Terminated

A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer (ILIAD)

Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Gastroesophageal Junction Adenocarcinoma | Carcinoma, Squamous Cell of Head and Neck

United States
GlaxoSmithKline
PPD

Completed

Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Spain, Germany, Hungary, Italy, Philippines, France, United States, Mexico, Brazil, South Africa, Korea, Republic of, Canada, Poland, United Kingdom
GlaxoSmithKline
PPD

Completed

Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

Hepatitis C, Chronic

Puerto Rico, United States
GlaxoSmithKline
PPD

Completed

4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease

Anaemia

United States, Germany, Canada, Sweden, Denmark, Norway
Genticel
PPD

Terminated

Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL

HPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL

United States
GlaxoSmithKline
PPD

Withdrawn

Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
Pfizer
PPD

Completed

A First In Human Study Of PF-00184562 In Healthy Volunteers

Schizophrenia

United States
GlaxoSmithKline
PPD

Terminated

A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour

Obstetric Labour, Premature

Belgium, Germany, Israel, Italy, Korea, Republic of, Mexico, Spain, Sweden, United Kingdom
GlaxoSmithKline
PPD

Completed

Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.

Hepatitis C, Chronic

Puerto Rico
GlaxoSmithKline
PPD

Completed

4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis

Anaemia

United States, Canada, Germany
GlaxoSmithKline
PPD

Completed

Dose Ranging of GSK2336805 in Combination Therapy (HAI115879)

Hepatitis C, Chronic

Puerto Rico, United States, Bulgaria, Germany, Belgium, France
Abbott
PPD

Completed

Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group (EXPO)

Non Alcoholic Fatty Liver Disease

France, Germany, Poland, Russian Federation
Allergy and Asthma Consultants, Wichita, Kansas
Aidan Foundation; Neil H. Riordan PhD

Completed

Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)

Duchenne's Muscular Dystrophy

United States
Utah State University
University of North Carolina, Chapel Hill; International OCD Foundation

Completed

Combining Acceptance and Commitment Therapy With Exposure and Response Prevention to Enhance Treatment Engagement

Obsessive-Compulsive Disorder

United States
AbbVie
PPD

Recruiting

Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications

Plaque Psoriasis | Crohn Disease | Psoriatic Arthritis | Other Conditions for Which Risankizumab is an FDA-approved Treatment

United States
GlaxoSmithKline
PPD

Active, not recruiting

A Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult Participants

Asthma

United States
GlaxoSmithKline
PPD

Completed

Belimumab (BENLYSTA®) Pregnancy Registry

Systemic Lupus Erythematosus

Belgium, Israel, United States, Italy, Argentina, Austria, Germany, Spain, Switzerland, France, Canada, Portugal, Sweden
Celltrion
PPD

Completed

A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Poland
GlaxoSmithKline
PPD

Terminated

A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor (NEWBORN-1)

Obstetric Labour, Premature

United States, Italy, United Kingdom, Japan, Canada
GlaxoSmithKline
PPD

Completed

Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies (ARIOS)

Obstetric Labour, Premature

Germany, Israel, Italy, Korea, Republic of, Mexico, Spain, Belgium, United Kingdom, Sweden, United States, Japan
PMD Solutions

Completed

Sensor Validation Study - Quality Assurance

Respiratory Rate

United Kingdom
PMD Solutions

Completed

RespiraSense Versus Capnography & Manual Counting

Respiratory Rate

United Kingdom
Fundacion Miguel Servet
Hospital Universitario Getafe; Matia Foundation

Unknown

Impact of a Multicomponent Exercise Program on Functional Capacity in Frail Aged Participants With Cognitive Decline

Cognitive Impairment | Frail Elderly Syndrome

Spain
H. Jaap Bonjer, PhD
Dutch Digestive Diseases Foundation

Terminated

Does Administration of Antibiotics in Patients Undergoing Surgery for Colorectal Cancer Result in Less Complications and Better Prognosis? (SELECT)

Colorectal Cancer

Netherlands
Karolinska Institutet
Karolinska University Hospital; The Swedish Research Council; Swedish Heart Lung... and other collaborators

Recruiting

Home Monitoring and Molecular Phenotyping of Patients With Post-COVID With Focus on Lung Involvement (HemCOV)

Long COVID

Sweden
Calmy Alexandra
University Hospital, Geneva; Swiss National Science Foundation; Swiss Heart Foundation and other collaborators

Terminated

ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART (NILACH)

Atherosclerosis | HIV

Switzerland
Paul Breslin, PhD
The Gerber Foundation

Not yet recruiting

Fortified Oral Rehydration Therapy for Pediatric Diarrhea (fORT)

Acute Gastroenteritis
Colin D. Weekes, M.D., PhD
Actuate Therapeutics Inc.; Lustgarten Foundation

Recruiting

FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer

Pancreatic Adenocarcinoma | Pancreatic Adenocarcinoma Metastatic

United States

Clinical Trials Sponsored by PCD Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations